NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - Moleculin Biotech, Inc. - 7.01 / 9.01
Filed:
2026-04-23
AccNo:
0001437749-26-013083
Size:
573 KB
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
发布时间04/23 12:25 UTC
首次发现04/23 12:29 UTC
热度105.3
重要度64
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 700 字符
Form 8-K - Current report: SEC Accession No. 0001437749-26-013083
Filing Date: 2026-04-23
Accepted: 2026-04-23 08:25:26
Documents: 16
Period of Report: 2026-04-23
Items: Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Moleculin Biotech, Inc. (Filer) CIK : 0001659617 (see all company filings) EIN. : 474671997 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 26885682 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 8-K | mbrx20260422_8k.htm iXBRL | 8-K
2 | EXHIBIT 99.1 | ex_949464.htm | EX-99.1
3 | EXHIBIT 99.2 | ex_949465.htm | EX-99.2
8 | aacr2026.jpg | GRAPHIC | 245776